Copy
View this email in your browser

The Business of Biotech Localized

Maryland, Virginia, Washington, D.C., and Philadelphia
It's been an action-packed JPM week, with lots of exciting news coming out of the BHCR and Philly! From clinical milestones to exciting real estate announcements, be sure to check out a snapshot below.

Please also join us in welcoming our newest team member, Ezekiel Kelley, to the BioBuzz crew! Ezekiel has an incredible story; beyond his stellar experience in operations and his passion for making an impact in the Baltimore community, he is also a talented musician.

Featured News

Infectious Disease Focused Zalgen Labs Opens
New HQ in Frederick, Eyes Clinical Trial for Lassa
Fever Therapeutic


Zalgen Labs is beginning 2022 with new digs in Frederick, Maryland and plans to file an investigational New Drug Application with the U.S. Food and Drug...

Ezekiel Kelley Joins Workforce Genetics as Director of Operations and Workforce Development Solutions

Workforce Genetics welcomes Ezekiel Kelley as the new Director of Operations and Workforce Development Solutions. Ezekiel will establish and implement...

5 Tips for PhD Students and Postdocs to Help Land That Non-Academic Job


When I started my PhD in 2012, I knew from the very beginning that I didn’t want to be in academia. However, I had no clue what else was out there...

5 Questions with Geeta Peverada, Ph.D., P.M.P., Program Manager, Quality Control at Catalent
Pharma Solutions


Geeta Peverada is a highly motivated, data-driven, and goal-oriented program management professional with over 12 years of experience in cancer research and...

Sponsored News

6 Biotechnology Trends to Look For in 2022

The biotechnology industry is ever-changing, evolving to improve the quality of life through research, digitization, advancements in preventive medicine, genetics, and more. Here are five...

Featured Employers

Jobs

 

Project Manager (Staff Scientist), Division of Preclinical Innovation, Therapeutic Development Branch

NIH/NCATS | Rockville, MD

The TDB partners with collaborators (e.g., academic institutions, foundations and private industry) to implement research and development projects leading to Investigational New Drug (IND) applications for new therapeutics. These projects play a leading role in NCATS’ mission to develop new ways to reduce, remove or bypass bottlenecks across the...

 

QC Analyst

BioFactura | Frederick, MD

We are looking for highly qualified candidates with a bachelor with two to five years experience supporting GMP QC Laboratories. Hand on experience with CE and HPLC instrumentation is highly preferred. The level of this position will be commensurate with candidate’s work experience. Responsibilities · Execute Raw Material, Drug Substance...


Senior Scientist - Cell Culture and Fermentation - Tech Transfer

AstraZeneca | Gaithersburg, MD

Do you have a passion for Science? Would you like to apply your expertise to impact a company that follows the science and turns ideas into life changing medicines? Then AstraZeneca might be the one for you! At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big...

JOB BOARD

Editors' Picks

REGENXBIO Announces FDA Clearance of IND for Clinical Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy

REGENXBIO Inc. (Nasdaq: RGNX) today announced the clearance of its Investigational New Drug (IND) application by the United States Food and Drug Administration (FDA) to evaluate RGX-202, a potential one-time gene therapy...

Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Development and Technical Operations Capability

Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has signed a long-term, full-building lease with Alexandria Real Estate Equities, Inc. to be the first tenant at the Alexandria Center® at Traville Gateway campus...

Texcell North America Marks Expansion by Breaking Ground for
New Facility


Texcell – North America, Inc., part of the Texcell Group of global biosafety contract research organizations, held a breaking ground ceremony for a new facility on December 6, 2021, in Frederick, MD. The expansion is a next step...

Moderna and Carisma Establish Collaboration to Develop 
in vivo Engineered Chimeric Antigen Receptor Monocytes
(CAR-M) for Oncology


Moderna Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Carisma Therapeutics Inc., a biopharmaceutical pioneer in engineered macrophage-based...

Avalo Reports Positive Phase 1b Results for AVTX-002 in Moderate to Severe Crohn’s Disease Patients and Presents Additional Program Updates at 2022 Investor Event

Immunology portfolio highlighted by success of a second positive study with AVTX-002 further validates the LIGHT mechanism of action in inflammatory diseases Efficacy signal demonstrated in heavily pre-treated subjects support...

#WayBackWednesday

Job Seekers See New Benefits As Employers Shift to Virtual Recruiting - Sept 2020

Yes, there are a lot of COVID-19 challenges that we continue to work through and overcome. But there have been some unexpected positives that have...

Events

WIB-National: Inclusion for People With Disabilities – What You Think You Know and Should Consider
January 27, 2022

Commit to becoming leaders among leaders in the disability inclusion space. You will have the unique opportunity to hear directly from deeply engaged leaders on this issue, including Former Congressman Tony Coelho, the...

RNA-Seq: Principles, Methods & Computational Analysis
February 7-11, 2022

This five day workshop is ideal for bench and research scientists who are looking for a solid foundation in RNA-Seq, from application, experimental design and sample preparation to post sequencing data processing analysis...

EVENT CALENDAR

Sponsors



Got a story worth buzzin' about? Drop us a line.
Facebook
Twitter
LinkedIn
YouTube
Instagram
Website
Copyright © 2021 BioBuzz, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.